Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene

Vaccine

Volumn 18, Issue 28, 2000, Pages 3242-3253

  Fló, Juan ^a   Beatriz Perez, Ana ^a   Tisminetzky, Sergio ^a   Baralle, Francisco ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

DNA vaccination; Herpes glycoprotein D; Herpes simplex virus

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HERPES SIMPLEX VIRUS 2; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VACCINATION; VIRUS INFECTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HERPESVIRUS 2, HUMAN; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; VACCINES, DNA; VAGINA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0342647478     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00132-8     Document Type: Article

References (34)

1. Eis-Hubinger A.M., Schmidt D.S., Schneweis K.E. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:1993;379-385.
2. Sherwood J.K., Zeitilin L., Whaley K.J., Cone R.A., Saltzman M. Controled release of antibodies for long term tropical passive immunoprotection of female mice against genital herpes. Nat. Biotechnol. 14:1996;468.
3. Brown Z.A., Seleke S., Zeh J., Kopelana J., Maslow A., Ashley R.L., Watts D.H., Berry S., Hern R.N., Corey L. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337:1997;509.
4. Milligan G.N., Bernstein D.I., Bourne N. T-lymphocytes are required for protection of vaginal mucosal and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 10:1998;6093-6100.
5. Parr M.B., Kepple L., McDermott M.R., Drew M.D., Bonzzola J.J., Parr E.L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex type 2. Lab. Invest. 70:1994;369-380.
6. Kuklin N.A., Daheshia M., Chun S., Rouse B.T. Role of mucosal immunity in herpes simplex virus infection. J. Immunol. 160:1998;5998-6003.
7. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:1997;3138-3145.
8. Manickan E., Rouse R.J., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:1995;259-265.
9. McDermott M.K., Goldsmith C.H., Rosenthal K.L., Brais L.J. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:1989;460-466.
10. Bernstein D.I., Tepe E.R., Mester J.C., Arnold R.L., Stanberry L.R., Higgins T. Effects of DNA immunized formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection. Vaccine. 17:(1516):1999;1964-1969.
11. Bourne N., Milligan G.N., Schleiss M.R., Bernstein D.I., Stanberry L.R. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine. 14:1996;1230-1234.
12. Bourne N., Stanberry L.R., Berstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:1996;800-807.
13. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA. 93:1996;11414-11420.
14. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 1982;Cold Spring Harbor Laboratory Press, New York.
15. Parr M.B., Parr E.L. Mucosal immunity to herpes simplex virus type 1 infection in the mouse vagina is impaired by in vivo depletion of T-lymphocytes. J. Virol. 72:1998;2677-2685.
16. Overall J.C., Kern E.R., Schlitzer R.L., Friedman S.B., Glasgow L.A. Genital herpes virus infection in mice. I. Development of an experimental model. Infect. Immun. 11:1975;476.
17. Cohen G.H., Dietzschold B., Ponce de Leon M., Long D., Golub E., Varrichio A., Pereira L., Eisenberg R.J. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J. Virol. 49:(1.1):1984;102-108.
18. Nicola A.V., Ponce de Leon M., Xu R., Hou W., Whitbeck J.C., Krummenacher C., Montgomery R.I., Spear P.G., Eisenberg R.J., Cohen G.H. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J. Virol. 72:1998;3595-3601.
19. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., De Witt C.M., Friedman A., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
20. Whitbeck J.C., Peng C., Lou H., Xu R., Willis S.H., Ponce de Leon M., Peng T., Nicola A.V., Montgomery R.I., Warner M.S., Soulika A.M., Spruce L.A., Moore W.T., Lambris J.D., Spear P.G., Cohen G.H., Eisenberg R.J. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71:1997;6083-6093.
21. Nicola A.V., Willis S.H., Naidoo N.N., Eisenberg R.J., Cohen G.H. Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J. Virol. 70:1996;3815-3822.
22. Förg P., von Hoegen P., Dalemans W., Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther. 5:1998;789-797.
23. Bouley D.M., Abrams M.E., Pumfery A.M., Brandt C.R. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:1995;3964-3971.
24. Milligan G., Bernstein I. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology. 229:1997;259-268.
25. Smith P.M., Wolcott R.M., Chervenak R., Jennings S.R. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology. 202:1994;76-88.
26. Milligan G., Bernstein I. Analysis of herpes simplex virus-specific T cells in murine female genital tract following genital infection with herpes simplex virus type 2. Virology. 212:1995;481-489.
27. Boyle J.S., Koniaras C., Lew A.M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9:1997;1897-1906.
28. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., Mahalingam S., Dang K., Ahn L., Doyle N.K., Wilson D.M., Chattergoon M.A., Chalian A.A., Boyer J.D., Agadjanyan M.G., Weiner D.B. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28:1998;1089-1103.
29. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
30. Sin J.I., Kim J.J., Ugen K.E., Ciccarelli R.B., Higgins T.J., Weiner D.B. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur. J. Immunol. 28:1998;3530-3540.
31. Tsuji T., Hamajima K., Fukushima J., Xin K.Q., Ishii N., Aoki I., Ishigatsubo Y., Tani K., Kawamoto S., Nitta Y., Miyazaki J., Koff W.C., Okubo T., Okuda K. Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158:1997;4008-4013.
32. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
33. Mosmann T.R., Coffman R.L. Two types of mouse helper T-cell clone: implication for immune regulation. Immunol. Today. 8:1987;223.
34. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7:1989;145.